Subscribe to Daily Review - your favourite M&A deals update.

Submit Deal

ADVANZ PHARMA CORP

Summary

Advanz Pharma Corp. Limited operates as a pharmaceutical company. The Company discovers endocrinology, ophthalmology, urology, anti-infectives, pain management, central nervous system disorders, and intensive care medicines. Advanz Pharma serves customers worldwide.

Deals Overview

Total Deals5

Valued Deals4

Total Value£ 4.37 B

Avg. Deal Size£ 1.09 B

Market Context

Senior Management

Graeme Duncan
CEO
Mark Thompson
Chairman and CEO
Steffen Wagner
CEO

Sort

robert sully

General Counsel at ADVANZ PHARMA CORP

Manager

Deal

£ 1.65 B

Total Value

graeme duncan

CEO at ADVANZ PHARMA CORP

Manager

Deals

£ 1.71 B

Total Value

mark thompson

Chairman and CEO at ADVANZ PHARMA CORP

Manager

Deal

£ 2.30 B

Total Value

meral nugent

Communications Director at ADVANZ PHARMA CORP

Manager

Deal

£ 1.65 B

Total Value

adeel ahmad

CFO at ADVANZ PHARMA CORP

Manager

Deal

£ 1.65 B

Total Value

susanna el-armale

Chief Corporate Development Officer at ADVANZ PHARMA CORP

Manager

Deal

£ 359 M

Total Value

steffen wagner

CEO at ADVANZ PHARMA CORP

Manager

Deals

£ 359 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy